hematology
Supportive Care and Other Tools for Managing Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
In patients who received prior CLL/SLL-directed therapy but require additional treatment, decisions may depend on ...
APRIL 29, 2025
FDA Approves Fibryga for Acquired Fibrinogen Deficiency
The FDA expanded the approval for Fibryga to include fibrinogen replacement in bleeding patients with acquired ...
AUGUST 6, 2024
FDA Approves Bkemv, Interchangeable Biosimilar to Soliris
The FDA approved Bkemv as the first interchangeable biosimilar to Soliris to treat two rare diseases that cause red ...
MAY 30, 2024
New Developments in Hemophilia Gene Therapy
Hemophilia is an X chromosome–linked genetic bleeding disorder caused by absent or defective clotting factor, ...
MAY 29, 2024
FDA Grants New Indication for Darzalex Faspro: Newly Diagnosed Light Chain Amyloidosis
Approximately 4,500 people in the United States develop this rare, but life-threatening blood cell disorder each ...
JANUARY 20, 2021
All Bloodstream Infections in Pediatric Hematology/Oncology Patients Should Be Tracked
All bloodstream infections in pediatric hematology/oncology patients, not simply central line–associated ...
APRIL 26, 2017
